DIABETES Add-on to metformin in T2DM-linagliptin or glimepiride?

被引：2

作者：

Christensen, Mikkel ^{[2
]}

Knop, Filip K. ^{[1
]}

机构：

[1] Univ Copenhagen, Diabet Res Div, Dept Internal Med, Gentofte Hosp, DK-2900 Hellerup, Denmark

[2] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark

来源：

NATURE REVIEWS ENDOCRINOLOGY | 2012年 / 8卷 / 10期

关键词：

HYPOGLYCEMIA; ASSOCIATION;

D O I：

10.1038/nrendo.2012.163

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Clinicians are responsible for selecting a suitable second-line treatment for patients with type 2 diabetes mellitus when metformin monotherapy fails. New evidence could aid clinicians in deciding between one of the most commonly used second-line agents, glimepiride, and the recently approved dipeptidyl peptidase 4 inhibitor linagliptin.

引用

页码：576 / 578

页数：3

共 10 条

[1] Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes [J].

Ahren, Bo ;

Schweizer, Anja ;

Dejager, Sylvie ;

Dunning, Beth E. ;

Nilsson, Peter M. ;

Persson, Margaretha ;

Foley, James E. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) :1236-1243

[2] The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study [J].

Bonds, Denise E. ;

Miller, Michael E. ;

Bergenstal, Richard M. ;

Buse, John B. ;

Byington, Robert P. ;

Cutler, Jeff A. ;

Dudl, R. James ;

Ismail-Beigi, Faramarz ;

Kimel, Angela R. ;

Hoogwerf, Byron ;

Horowitz, Karen R. ;

Savage, Peter J. ;

Seaquist, Elizabeth R. ;

Simmons, Debra L. ;

Sivitz, William I. ;

Speril-Hillen, Joann M. ;

Sweeney, Mary Ellen .

BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 :137

[3] Differential effects of sulfonylurea derivatives on vascular ATP-sensitive potassium channels [J].

Engbersen, Richard ;

Masereeuw, Rosalinde ;

van Gestel, Miriam A. ;

Siero, Helene L. M. ;

Moons, Miek M. ;

Smits, Paul ;

Russel, Frans G. M. .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 681 (1-3) :75-79

[4] 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial [J].

Gallwitz, Baptist ;

Rosenstock, Julio ;

Rauch, Thomas ;

Bhattacharya, Sudipta ;

Patel, Sanjay ;

von Eynatten, Maximilian ;

Dugi, Klaus A. ;

Woerle, Hans-Juergen .

LANCET, 2012, 380 (9840) :475-483

[5] Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration [J].

Heller, S. R. ;

Choudhary, P. ;

Davies, C. ;

Emery, C. ;

Campbell, M. J. ;

Freeman, J. ;

Amiel, S. A. ;

Malik, R. ;

Frier, B. M. ;

Allen, K. V. ;

Zammitt, N. N. ;

Macleod, K. ;

Lonnen, K. F. ;

Kerr, D. ;

Richardson, T. ;

Hunter, S. ;

Mclaughlin, D. .

DIABETOLOGIA, 2007, 50 (06) :1140-1147

[6] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [J].

Inzucchi, S. E. ;

Bergenstal, R. M. ;

Buse, J. B. ;

Diamant, M. ;

Ferrannini, E. ;

Nauck, M. ;

Peters, A. L. ;

Tsapas, A. ;

Wender, R. ;

Matthews, D. R. .

DIABETOLOGIA, 2012, 55 (06) :1577-1596

[7] Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes [J].

Landstedt-Hallin, L ;

Adamson, U ;

Lins, PE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) :3140-3145

[8] Sulfonylurea induced β-cell apoptosis in cultured human islets [J].

Maedler, K ;

Carr, RD ;

Bosco, D ;

Zuellig, RA ;

Berney, T ;

Donath, MY .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :501-506

[9] The effect of glucagon-like peptide 1 on cardiovascular risk [J].

Sivertsen, Jacob ;

Rosenmeier, Jaya ;

Holst, Jens J. ;

Vilsboll, Tina .

NATURE REVIEWS CARDIOLOGY, 2012, 9 (04) :209-222

[10]

TURNER RC, 1995, DIABETES, V44, P1249

← 1 →